☰

Aaron D. Tward, Ph.D. - Publications

Affiliations: 
2005 University of California, San Francisco, San Francisco, CA 
Area:
Molecular Biology, Genetics, Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Planells-Palop V, Koo A, Malave H, Lee K, Tward A. Abstract B40: Minimal mutational determinants of human squamous cell carcinoma Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-B40  0.301
2019 Adams CR, Htwe HH, Marsh T, Wang AL, Montoya ML, Subbaraj L, Tward AD, Bardeesy N, Perera RM. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. Elife. 8. PMID 31134896 DOI: 10.7554/Elife.45313  0.324
2018 Byrnes LE, Wong DM, Subramaniam M, Meyer NP, Gilchrist CL, Knox SM, Tward AD, Ye CJ, Sneddon JB. Lineage dynamics of murine pancreatic development at single-cell resolution. Nature Communications. 9: 3922. PMID 30254276 DOI: 10.1038/S41467-018-06176-3  0.3
2018 Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, ... ... Tward AD, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 173: 321-337.e10. PMID 29625050 DOI: 10.1016/J.Cell.2018.03.035  0.348
2017 Farmer D, Nathan S, Finley J, Yu KS, Emmerson E, Byrnes L, Sneddon J, McManus M, Tward A, Knox S. Defining epithelial cell dynamics and lineage relationships in the developing lacrimal gland. Development (Cambridge, England). PMID 28576768 DOI: 10.1242/Dev.150789  0.32
2015 Li J, Chanrion M, Sawey E, Wang T, Chow E, Tward A, Su Y, Xue W, Lucito R, Zender L, Lowe SW, Bishop JM, Powers S. Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma. Plos One. 10: e0118480. PMID 25738607 DOI: 10.1371/Journal.Pone.0118480  0.309
2014 Rocco JW, Tward AD, Ren Y, Hammon RJ, Mroz EA. Mutant-Allele Tumor Heterogeneity (MATH) Adds to Human Papillomavirus (HPV) Status in Predicting Outcome in Head-and-Neck Squamous Cell Carcinoma (HNSCC) International Journal of Radiation Oncology Biology Physics. 88: 467-468. DOI: 10.1016/J.Ijrobp.2013.11.027  0.302
2013 Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer. 119: 3034-42. PMID 23696076 DOI: 10.1002/Cncr.28150  0.312
2011 Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, et al. The mutational landscape of head and neck squamous cell carcinoma. Science (New York, N.Y.). 333: 1157-60. PMID 21798893 DOI: 10.1126/Science.1208130  0.345
2011 Stransky N, Egloff AM, Tward A, Auclair D, Cibulskis K, Lawrence M, Sivachenko A, Berger M, Seethala R, Sougnez C, Cortes M, Winckler W, Gabriel S, Getz G, Golub T, et al. Abstract 3931: Whole genome and whole exome sequencing of head and neck cancer Cancer Research. 71: 3931-3931. DOI: 10.1158/1538-7445.Am2011-3931  0.326
2008 Lee SA, Ho C, Roy R, Kosinski C, Patil MA, Tward AD, Fridlyand J, Chen X. Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer. Hepatology (Baltimore, Md.). 47: 1200-10. PMID 18214995 DOI: 10.1002/Hep.22169  0.357
2007 Tward AD, Jones KD, Yant S, Cheung ST, Fan ST, Chen X, Kay MA, Wang R, Bishop JM. Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proceedings of the National Academy of Sciences of the United States of America. 104: 14771-6. PMID 17785413 DOI: 10.1073/Pnas.0706578104  0.339
2007 Goga A, Yang D, Tward AD, Morgan DO, Bishop JM. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nature Medicine. 13: 820-7. PMID 17589519 DOI: 10.1038/Nm1606  0.308
2006 Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proceedings of the National Academy of Sciences of the United States of America. 103: 14842-7. PMID 17003113 DOI: 10.1073/Pnas.0606857103  0.376
2006 Sheth SS, Bodnar JS, Ghazalpour A, Thipphavong CK, Tsutsumi S, Tward AD, Demant P, Kodama T, Aburatani H, Lusis AJ. Hepatocellular carcinoma in Txnip-deficient mice. Oncogene. 25: 3528-36. PMID 16607285 DOI: 10.1038/Sj.Onc.1209394  0.348
2005 Tward AD, Jones KD, Yant S, Kay MA, Wang R, Bishop JM. Genomic progression in mouse models for liver tumors. Cold Spring Harbor Symposia On Quantitative Biology. 70: 217-24. PMID 16869757 DOI: 10.1101/Sqb.2005.70.058  0.351
2005 Furlong CE, Cole TB, Jarvik GP, Pettan-Brewer C, Geiss GK, Richter RJ, Shih DM, Tward AD, Lusis AJ, Costa LG. Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants. Neurotoxicology. 26: 651-9. PMID 16112327 DOI: 10.1016/J.Neuro.2004.08.002  0.308
Show low-probability matches.